CELL-DYN RETICULOCYTEREAGENT - COFEPRIS Registration 0797R2022 SSA
Access comprehensive regulatory information for CELL-DYN RETICULOCYTEREAGENT (CELL-DYN RETICULOCYTEREAGENT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0797R2022 SSA and manufactured by ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on August 16, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL CELL-DYN RETICULOCYTE REAGENT, UTILIZADO ENCOMBINACIÓNCONCELL-DYNRUBYPERMITEDETERMINARLOS RETICULOCITOS EN UN ESPÉCIMEN DE SANGRE. AGENTE DEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVOEN LABORATORIOS CLÍNICOS O DE GABINETE.
THE CELL-DYN RETICULOCYTE REAGENT, USED IN COMBINATION WITH CELL-DYNRUBY, ALLOWS RETICULOCYTES TO BE DETERMINED IN A BLOOD SPECIMEN. DIAGNOSTIC AGENT for use in the hospital. FOR USE ONLY IN CLINICAL OR OFFICE LABORATORIES.